SPARSH BIOTECH is rapidly establishing itself as a significant player in the medicinal sector, notably recognized for its innovative process of producing Amoxicilline and Augmentin. The company boasts state-of-the-art infrastructure and a committed team providing high-quality drugs serving patients worldwide . Via stringe